Oct 2026· European Journal of Pediatrics· Vol 185· 0 citations· 17 references
Medicine
TL;DR
The findings support the clinical value of genetic testing in familial hypercholesterolemia, both for improving diagnostic accuracy and for promoting earlier therapeutic intervention and adherence.
Heterozygous familial hypercholesterolemia (HeFH) is an autosomal dominant disorder characterized by elevated LDL-cholesterol (LDL-C) levels from childhood. Increased lipoprotein(a)[Lp(a)] levels, a genetically determined risk factor for atherosclerotic events, may influence the clinical presentation of FH. Howev...
K. M. B. Borges, F. Juliani, M. Castelo et al.· European Heart Journal· 0 citations
Background. Familial hypercholesterolemia (FH) is a common autosomal dominant genetic disorder associated with premature atherosclerotic cardiovascular disease. Despite established international guidelines, FH remains substantially underdiagnosed, particularly in young adults.
Aim. This narrative review summarizes curr...
Jakub Dyczko, Filip Kruczek, K. Mączka et al.· International Journal of Inn...· 0 citations
Abstract Familial hypercholesterolemia (FH) is a common genetic disorder causing elevated low-density lipoprotein cholesterol (LDL-c) concentrations from birth, resulting in a high risk of premature cardiovascular disease. Despite effective early treatment, FH remains underdiagnosed in children, highlighting the need f...
Vera H. de Kleijne, B. Hutten, A. Boelen et al.· Clinical Chemistry and Labor...· 0 citations
As the diagnosis of HoFH continues to evolve, future diagnostic criteria should place less emphasis on genetics and greater emphasis on modern clinical applications to ensure that all individuals with HoFH have access to the most appropriate therapies to reduce their risk of premature ASCVD and death resulting from pro...
Daniel Gaudet, R. Godin, R. Rosenson et al.· Journal of Clinical Lipidolo...· 0 citations
One-time nutritional advice had little effect on LDL-C in general, but particularly in FH, highlighting on the one hand need for structured lifestyle programs and on the other hand early genetic testing in population based FH screening.
S. Arens, U. Šuštar, K. Lange et al.· Lipids in Health and Disease· 0 citations
BACKGROUND
Reverse cascade genetic screening, following initial lipid testing, is an effective strategy for the early diagnosis of familial hypercholesterolemia (FH) and related hereditary dyslipidemias. In this study, we present the results of a pilot project in Russia.
METHODS
This was a hybrid retrospective-prospe...
V. Miroshnikova, A. Izyumchenko, N. N. Smirnova et al.· Frontiers in Bioscience· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.